Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

177Lu-DOTATATE for Recurrent Meningioma: a Randomized Phase II Study

NCT06326190 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.

NCT NCT06326190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06326190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
177Lu-DOTATATE for Recurrent Meningioma: a Randomized Phase II Study
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Phase
Phase 2
Overall status
Recruiting
Start date
March 10, 2025
Completion date
December 22, 2028
Enrollment
136 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent meningioma